Literature DB >> 28931606

Asparagine and glutamine ladders promote cross-species prion conversion.

Timothy D Kurt1, Patricia Aguilar-Calvo1, Lin Jiang2, José A Rodriguez3,4,5, Nazilla Alderson1, David S Eisenberg3,4, Christina J Sigurdson6,7.   

Abstract

Prion transmission between species is governed in part by primary sequence similarity between the infectious prion aggregate, PrPSc, and the cellular prion protein of the host, PrPC A puzzling feature of prion formation is that certain PrPC sequences, such as that of bank vole, can be converted by a remarkably broad array of different mammalian prions, whereas others, such as rabbit, show robust resistance to cross-species prion conversion. To examine the structural determinants that confer susceptibility or resistance to prion conversion, we systematically tested over 40 PrPC variants of susceptible and resistant PrPC sequences in a prion conversion assay. Five key residue positions markedly impacted prion conversion, four of which were in steric zipper segments where side chains from amino acids tightly interdigitate in a dry interface. Strikingly, all five residue substitutions modulating prion conversion involved the gain or loss of an asparagine or glutamine residue. For two of the four positions, Asn and Gln residues were not interchangeable, revealing a strict requirement for either an Asn or Gln residue. Bank voles have a high number of Asn and Gln residues and a high Asn:Gln ratio. These findings suggest that a high number of Asn and Gln residues at specific positions may stabilize β-sheets and lower the energy barrier for cross-species prion transmission, potentially because of hydrogen bond networks from side chain amides forming extended Asn/Gln ladders. These data also suggest that multiple PrPC segments containing Asn/Gln residues may act in concert along a replicative interface to promote prion conversion.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  amyloid; fibril; neurodegeneration; prion; prion disease; steric zipper; transmission

Mesh:

Substances:

Year:  2017        PMID: 28931606      PMCID: PMC5704488          DOI: 10.1074/jbc.M117.794107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Toward high-resolution de novo structure prediction for small proteins.

Authors:  Philip Bradley; Kira M S Misura; David Baker
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

2.  Characterization of the prion protein 3F4 epitope and its use as a molecular tag.

Authors:  Christoffer Lund; Christel Moraeus Olsen; Heidi Tveit; Michael A Tranulis
Journal:  J Neurosci Methods       Date:  2007-06-13       Impact factor: 2.390

3.  Dynamics of locking of peptides onto growing amyloid fibrils.

Authors:  Govardhan Reddy; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

Review 4.  Structural Studies of Amyloid Proteins at the Molecular Level.

Authors:  David S Eisenberg; Michael R Sawaya
Journal:  Annu Rev Biochem       Date:  2017-01-03       Impact factor: 23.643

5.  Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion.

Authors:  L Z Osherovich; J S Weissman
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

6.  Complex System Assembly Underlies a Two-Tiered Model of Highly Delocalized Electrons.

Authors:  Miguel Mompeán; Aurora Nogales; Tiberio A Ezquerra; Douglas V Laurents
Journal:  J Phys Chem Lett       Date:  2016-05-06       Impact factor: 6.475

7.  A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.

Authors:  S A Priola; B Chesebro
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity.

Authors:  Pascal Krotee; Jose A Rodriguez; Michael R Sawaya; Duilio Cascio; Francis E Reyes; Dan Shi; Johan Hattne; Brent L Nannenga; Marie E Oskarsson; Stephan Philipp; Sarah Griner; Lin Jiang; Charles G Glabe; Gunilla T Westermark; Tamir Gonen; David S Eisenberg
Journal:  Elife       Date:  2017-01-03       Impact factor: 8.140

9.  Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles.

Authors:  Romolo Nonno; Michele A Di Bari; Franco Cardone; Gabriele Vaccari; Paola Fazzi; Giacomo Dell'Omo; Claudia Cartoni; Loredana Ingrosso; Aileen Boyle; Roberta Galeno; Marco Sbriccoli; Hans-Peter Lipp; Moira Bruce; Maurizio Pocchiari; Umberto Agrimi
Journal:  PLoS Pathog       Date:  2006-02-24       Impact factor: 6.823

10.  Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.

Authors:  Laura Pirisinu; Michele A Di Bari; Claudia D'Agostino; Stefano Marcon; Geraldina Riccardi; Anna Poleggi; Mark L Cohen; Brian S Appleby; Pierluigi Gambetti; Bernardino Ghetti; Umberto Agrimi; Romolo Nonno
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

View more
  9 in total

1.  Glutamine Side Chain 13C═18O as a Nonperturbative IR Probe of Amyloid Fibril Hydration and Assembly.

Authors:  Haifan Wu; Daniel J Saltzberg; Huong T Kratochvil; Hyunil Jo; Andrej Sali; William F DeGrado
Journal:  J Am Chem Soc       Date:  2019-04-24       Impact factor: 15.419

Review 2.  Understanding and controlling amyloid aggregation with chirality.

Authors:  Alejandro R Foley; Jevgenij A Raskatov
Journal:  Curr Opin Chem Biol       Date:  2021-02-18       Impact factor: 8.972

3.  Structural analysis of cross α-helical nanotubes provides insight into the designability of filamentous peptide nanomaterials.

Authors:  Fengbin Wang; Ordy Gnewou; Charles Modlin; Leticia C Beltran; Chunfu Xu; Zhangli Su; Puneet Juneja; Gevorg Grigoryan; Edward H Egelman; Vincent P Conticello
Journal:  Nat Commun       Date:  2021-01-18       Impact factor: 14.919

4.  Involvement of N- and C-terminal region of recombinant cervid prion protein in its reactivity to CWD and atypical BSE prions in real-time quaking-induced conversion reaction in the presence of high concentrations of tissue homogenates.

Authors:  Akio Suzuki; Kazuhei Sawada; Takeshi Yamasaki; Nathaniel D Denkers; Candace K Mathiason; Edward A Hoover; Motohiro Horiuchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

5.  Micro-electron diffraction structure of the aggregation-driving N terminus of Drosophila neuronal protein Orb2A reveals amyloid-like β-sheets.

Authors:  Jeannette T Bowler; Michael R Sawaya; David R Boyer; Duilio Cascio; Manya Bali; David S Eisenberg
Journal:  J Biol Chem       Date:  2022-08-18       Impact factor: 5.486

6.  Sub-ångström cryo-EM structure of a prion protofibril reveals a polar clasp.

Authors:  Marcus Gallagher-Jones; Calina Glynn; David R Boyer; Michael W Martynowycz; Evelyn Hernandez; Jennifer Miao; Chih-Te Zee; Irina V Novikova; Lukasz Goldschmidt; Heather T McFarlane; Gustavo F Helguera; James E Evans; Michael R Sawaya; Duilio Cascio; David S Eisenberg; Tamir Gonen; Jose A Rodriguez
Journal:  Nat Struct Mol Biol       Date:  2018-01-15       Impact factor: 15.369

7.  Unique Structural Features of Mule Deer Prion Protein Provide Insights into Chronic Wasting Disease.

Authors:  Urška Slapšak; Giulia Salzano; Gregor Ilc; Gabriele Giachin; Jifeng Bian; Glenn Telling; Giuseppe Legname; Janez Plavec
Journal:  ACS Omega       Date:  2019-11-15

8.  Asparagine and Glutamine Side-Chains and Ladders in HET-s(218-289) Amyloid Fibrils Studied by Fast Magic-Angle Spinning NMR.

Authors:  Thomas Wiegand; Alexander A Malär; Riccardo Cadalbert; Matthias Ernst; Anja Böckmann; Beat H Meier
Journal:  Front Mol Biosci       Date:  2020-09-30

9.  Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.

Authors:  Cassandra M Burke; Kenneth M K Mark; Daniel J Walsh; Geoffrey P Noble; Alexander D Steele; Abigail B Diack; Jean C Manson; Joel C Watts; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2020-09-08       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.